Atomo Diagnostics Limited (AT1.AX)

AUD 0.02

(-5.0%)

Market Cap (In AUD)

12.14 Million

Revenue (In AUD)

4.08 Million

Net Income (In AUD)

-6.84 Million

Avg. Volume

286.76 Thousand

Currency
AUD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.018-0.06
PE
-
EPS
-
Beta Value
0.895
ISIN
AU0000080327
CUSIP
Q0611N102
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. John Michael Kelly
Employee Count
-
Website
https://atomodiagnostics.com
Ipo Date
2020-04-16
Details
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for COVID-19, HIV screening, pregnancy test, and respiratory test. The company was incorporated in 2010 and is headquartered in Leichhardt, Australia.

More Stocks